CONFERENCE HIGHLIGHTS

Robbins Learning Pavilion, RAH | November 7, 2026

cv-update-home1

WHAT IS THE CV UPDATE?

This one-day course will provide participants with practical and up to date information on the management of cardiac problems in the primary care setting. The conference will include a combination of workshops, presentations, and short snappers, as well as opportunities for the delegates and faculty to interact.

WHO SHOULD ATTEND?

Urban and rural primary care physicians as well as internists, ER doctors, nurse and nurse practitioners, fellows, residents, medical students, and allied health professionals.

WHAT ARE THE 2026 COURSE OBJECTIVES?

After attending this conference participants will be able to:
  1. Apply the 2026 hypertension guidelines to assess and treat hypertension in contemporary clinical practice.
  2. Recognize the cardiovascular implications of menopause and hormone therapy and incorporate these considerations into cardiovascular risk assessment and prevention in women.
  3. Interpret common ECG, Holter, and cardiac device findings and identify abnormalities that require further investigation or specialist referral.
  4. Recognize and appropriately investigate common valvular heart disease presentations, including when to refer patients for contemporary medical or transcatheter therapies.
  5. Select appropriate outpatient cardiac investigations based on a patient’s symptoms, cardiovascular risk, and pre-test probability while avoiding unnecessary testing.
  6. Optimize cardiovascular risk reduction in patients with established ASCVD, including therapies beyond statins and the appropriate use and interpretation of lipoprotein(a) testing.
  7. Apply contemporary, individualized approaches to heart failure management, incorporating current guideline-directed therapies and patient-specific factors.
  8. Integrate emerging approaches to cardiovascular prevention and healthy longevity, including risk-factor modification, vaccination, and evolving strategies to reduce lifetime cardiovascular risk.